Neuroblastoma is a type of cancer that develops from immature nerve cells, or neurons, of the sympathetic nervous system. This system is part of the autonomic nervous system, which plays a vital role in controlling essential body functions such as breathing, blood pressure, and digestion.
Neuroblastoma can sometimes present with no obvious symptoms, and its signs can often be mistaken for those of other, more common conditions. The symptoms a child experiences depend on the tumour's location, size, whether the cancer has spread, and if it is producing hormones.
Possible symptoms may include:
In the abdomen, lower back, neck, or chest
If the cancer has spread to the bone
Bulging eyes, drooping eyelid, or dark circles under or around the eyes
A swollen, distended stomach
Breathing difficulties or coughing
In the lower limbs
Fever, anaemia, and high blood pressure
Of the legs or scrotum
Problems with urination or bowel movements
Important: It is important to remember that most children with these symptoms do not have neuroblastoma; they are typically caused by less serious issues. However, it is always advisable to consult a paediatrician to address any health concerns.
Neuroblastoma can be challenging to diagnose. The highly specialised experts at SSCHRC possess extensive experience and employ the most advanced technology to accurately pinpoint the disease. This commitment helps ensure the delivery of the most effective treatments with minimal impact on your child's developing body.
As neuroblastoma often has few early symptoms, it may metastasise (spread) to other parts of the body before it is discovered. In rare early stages, it might be found during routine medical examinations.
If your child's doctor suspects neuroblastoma, the initial step involves a thorough physical examination, along with a detailed discussion about your child's health history.
One or more of the following diagnostic tests may be used to confirm a diagnosis, determine if the cancer has spread, and monitor the effectiveness of treatment:
Several imaging methods can be used to visualise the tumour and check for spread:
If an imaging test detects a tumour, a biopsy is performed to confirm if it is neuroblastoma. This involves a doctor removing a small sample of cells for examination under a microscope. A biopsy is typically performed in one of two ways:
Treatment for neuroblastoma is often complex and requires a multi-speciality approach. SSCHRC offers a comprehensive team approach, bringing together leading oncologists, surgeons, radiologists, and radiation oncologists, along with highly specialised support staff, to personalise your child's treatment plan. Their goal is to deliver therapies that offer the highest chance of success while minimising the impact on the child's growing body.
Key factors influencing treatment options are:
While some low-risk neuroblastoma tumours may resolve without treatment, and others can be cured by surgery alone, aggressive treatment combinations are often required if the cancer has spread.
Treatment modalities include:
Children with advanced neuroblastoma may benefit from this specialised form of treatment. A radioactive chemical is injected into the bloodstream, travelling directly to the neuroblastoma tumour cells throughout the body.
A stem cell transplant may be beneficial for children with treatment-resistant or advanced neuroblastoma.
Treatment involving Vitamin A or a Vitamin A-like compound may be prescribed for some patients.
SSCHRC is at the forefront of neuroblastoma treatment, developing innovative targeted therapies. These agents are specifically designed to attack the unique genetic and molecular profile of each cancer to help a child's body fight the disease. Many doctors who treat neuroblastoma at SSCHRC are dedicated researchers who actively lead national and international clinical trials for these novel agents.